These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8216758)

  • 21. Total tau in cerebrospinal fluid differentiates Alzheimer's disease from vascular dementia.
    Leszek J; Małyszczak K; Janicka B; Kiejna A; Wiak A
    Med Sci Monit; 2003 Nov; 9(11):CR484-8. PubMed ID: 14586274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.
    Jia JP; Meng R; Sun YX; Sun WJ; Ji XM; Jia LF
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):12-6. PubMed ID: 15936505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSF/serum folate gradient: physiology and determinants with special reference to dementia.
    Hagnelius NO; Wahlund LO; Nilsson TK
    Dement Geriatr Cogn Disord; 2008; 25(6):516-23. PubMed ID: 18463447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy.
    Schmitz M; Hermann P; Oikonomou P; Stoeck K; Ebert E; Poliakova T; Schmidt C; Llorens F; Zafar S; Zerr I
    Neurobiol Aging; 2015 Sep; 36(9):2597-606. PubMed ID: 26170132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease.
    Tohgi H; Abe T; Takahashi S; Kikuchi T
    J Neural Transm Park Dis Dement Sect; 1993; 6(2):119-26. PubMed ID: 8117408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia.
    Treves TA; Bornstein NM; Chapman J; Klimovitzki S; Verchovsky R; Asherov A; Veshchev IO; Korczyn AD
    Alzheimer Dis Assoc Disord; 1996; 10(4):189-91. PubMed ID: 8939277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia.
    Yamada K; Kono K; Umegaki H; Yamada K; Iguchi A; Fukatsu T; Nakashima N; Nishiwaki H; Shimada Y; Sugita Y
    Neurosci Lett; 1995 Feb; 186(2-3):219-21. PubMed ID: 7777201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.
    Andreasen N; Vanmechelen E; Van de Voorde A; Davidsson P; Hesse C; Tarvonen S; Räihä I; Sourander L; Winblad B; Blennow K
    J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):298-305. PubMed ID: 9527138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia.
    Arai H; Satoh-Nakagawa T; Higuchi M; Morikawa Y; Miura M; Kawakami H; Seki H; Takase S; Sasaki H
    Neurosci Lett; 1998 Nov; 256(3):174-6. PubMed ID: 9855368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamate and other CSF amino acids in Alzheimer's disease.
    Pomara N; Singh R; Deptula D; Chou JC; Schwartz MB; LeWitt PA
    Am J Psychiatry; 1992 Feb; 149(2):251-4. PubMed ID: 1734749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
    Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
    J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N(epsilon)(gamma-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia.
    Nemes Z; Fésüs L; Egerházi A; Keszthelyi A; Degrell IM
    Neurobiol Aging; 2001; 22(3):403-6. PubMed ID: 11378245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer's Disease.
    Brombo G; Bonetti F; Ortolani B; Morieri ML; Bosi C; Passaro A; Vigna GB; Borgna C; Arcidicono MV; Tisato V; Zuliani G
    Gerontology; 2018; 64(5):414-421. PubMed ID: 29768278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.
    Smesny S; Stein S; Willhardt I; Lasch J; Sauer H
    J Neural Transm (Vienna); 2008 Aug; 115(8):1173-9. PubMed ID: 18584113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients.
    Costa M; Horrillo R; Ortiz AM; Pérez A; Mestre A; Ruiz A; Boada M; Grancha S
    J Alzheimers Dis; 2018; 63(4):1395-1404. PubMed ID: 29782326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Smith CC; Bowen DM; Francis PT; Snowden JS; Neary D
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):469-71. PubMed ID: 2860210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease.
    Brettschneider J; Petzold A; Schottle D; Claus A; Riepe M; Tumani H
    Dement Geriatr Cogn Disord; 2006; 21(5-6):291-5. PubMed ID: 16484807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.
    Skoog I; Wallin A; Fredman P; Hesse C; Aevarsson O; Karlsson I; Gottfries CG; Blennow K
    Neurology; 1998 Apr; 50(4):966-71. PubMed ID: 9566380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress in Alzheimer's and vascular dementias: masking of the antioxidant profiles by a concomitant Type II diabetes mellitus condition.
    Serra JA; Marschoff ER; Domínguez RO; Guareschi EM; Famulari AL; Pagano MA; de Lustig ES;
    J Neurol Sci; 2004 Mar; 218(1-2):17-24. PubMed ID: 14759628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy.
    Schönknecht P; Pantel J; Hartmann T; Werle E; Volkmann M; Essig M; Amann M; Zanabili N; Bardenheuer H; Hunt A; Schröder J
    Psychiatry Res; 2003 Oct; 120(3):231-8. PubMed ID: 14561434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.